AC Immune makes management appointments
This article was originally published in Scrip
Executive Summary
AC Immune, a Swiss company focused on Alzheimer's disease drug development, has appointed Jean-Fabien Monin chief financial officer and Dr Michael Wagener chief medical director. Mr Monin brings 14 years experience at bioMérieux, where he served as CFO Central Europe. Dr Wagener spent 11 years at Novartis serving as clinical programmedirector for all global Phase I-IV clinical studies in immunology.